US Stock MarketDetailed Quotes
ELAN Elanco Animal Health
- 13.360
- -0.040-0.30%
Close Nov 22 16:00 ET
- 13.360
- 0.0000.00%
Post 16:48 ET
6.60BMarket Cap32.59P/E (TTM)
13.460High13.150Low3.63MVolume13.370Open13.400Pre Close48.50MTurnover0.74%Turnover RatioLossP/E (Static)494.35MShares18.80052wk High1.01P/B6.57BFloat Cap11.40052wk Low--Dividend TTM491.80MShs Float37.610Historical High--Div YieldTTM2.31%Amplitude7.880Historical Low13.351Avg Price1Lot Size
Elanco Animal Health Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.56%1.03B | 12.02%1.18B | -4.14%1.21B | 0.14%4.42B | 5.08%1.04B | 4.09%1.07B | -10.04%1.06B | 2.53%1.26B | -7.41%4.41B | -11.42%985M |
| Operating revenue | -3.56%1.03B | 12.02%1.18B | -4.14%1.21B | 0.14%4.42B | 5.08%1.04B | 4.09%1.07B | -10.04%1.06B | 2.53%1.26B | -7.41%4.41B | -11.42%985M |
| Cost of revenue | 1.03%492M | 14.06%495M | 4.25%515M | 0.94%1.93B | 15.18%516M | 3.18%487M | -10.33%434M | -2.95%494M | -10.27%1.91B | -12.16%448M |
| Gross profit | -7.40%538M | 10.59%689M | -9.57%690M | -0.48%2.49B | -3.35%519M | 4.87%581M | -9.84%623M | 6.42%763M | -5.09%2.5B | -10.80%537M |
| Operating expense | 0.74%543M | 0.70%574M | 2.77%557M | 2.18%2.16B | -0.59%509M | 6.94%539M | 2.15%570M | 0.18%542M | -9.19%2.11B | -8.41%512M |
| Selling and administrative expenses | 3.19%323M | 0.28%354M | 3.06%337M | 1.58%1.29B | -3.31%292M | 5.03%313M | 2.92%353M | 1.24%327M | -9.84%1.27B | -7.93%302M |
| Research and development costs | 1.16%87M | 9.88%89M | 7.41%87M | 1.87%327M | -1.25%79M | 10.26%86M | -1.22%81M | 0.00%81M | -13.01%321M | -13.04%80M |
| Depreciation amortization depletion | -5.00%133M | -3.68%131M | -0.75%133M | 3.79%548M | 6.15%138M | 9.38%140M | 2.26%136M | -2.19%134M | -5.04%528M | -6.47%130M |
| -Depreciation and amortization | -5.00%133M | -3.68%131M | -0.75%133M | 3.79%548M | 6.15%138M | 9.38%140M | 2.26%136M | -2.19%134M | -5.04%528M | -6.47%130M |
| Operating profit | -111.90%-5M | 116.98%115M | -39.82%133M | -15.10%326M | -60.00%10M | -16.00%42M | -60.15%53M | 25.57%221M | 26.32%384M | -41.86%25M |
| Net non-operating interest income expense | 19.44%-58M | 12.16%-65M | -3.13%-66M | -14.94%-277M | -8.06%-67M | -20.00%-72M | -10.45%-74M | -23.08%-64M | -2.12%-241M | -12.73%-62M |
| Non-operating interest expense | -19.44%58M | -12.16%65M | 3.13%66M | 14.94%277M | 8.06%67M | 20.00%72M | 10.45%74M | 23.08%64M | 2.12%241M | 12.73%62M |
| Other net income (expense) | 158.29%622M | -41.38%-82M | -12.24%-55M | -478.60%-1.24B | -34.62%-70M | -3,038.24%-1.07B | 27.50%-58M | 0.00%-49M | 66.35%-215M | 53.98%-52M |
| Special income (charges) | 158.88%623M | -128.57%-80M | -15.00%-46M | -538.80%-1.17B | -16.13%-36M | -3,969.23%-1.06B | 59.30%-35M | 0.00%-40M | 71.14%-183M | 65.56%-31M |
| -Less：Restructuring and merger&acquisition | -81.82%2M | -60.00%14M | 15.00%46M | -5.10%93M | -75.00%7M | -59.26%11M | 40.00%35M | 122.22%40M | -63.97%98M | -73.33%28M |
| -Less:Impairment of capital assets | -98.57%15M | --61M | ---- | 1,225.93%1.07B | 2,800.00%27M | 104,800.00%1.05B | --0 | ---- | -76.86%81M | -108.33%-1M |
| -Less:Other special charges | ---- | ---- | ---- | -50.00%2M | ---- | ---- | ---- | ---- | -66.67%4M | ---- |
| -Write off | --0 | --5M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Gain on sale of business | --640M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | 88.89%-1M | 91.30%-2M | 0.00%-9M | -134.38%-75M | -61.90%-34M | -12.50%-9M | -483.33%-23M | 0.00%-9M | -540.00%-32M | 8.70%-21M |
| Income before tax | 150.96%559M | 59.49%-32M | -88.89%12M | -1,559.72%-1.2B | -42.70%-127M | -2,393.18%-1.1B | -464.29%-79M | 44.00%108M | 87.39%-72M | 28.80%-89M |
| Income tax | 19,600.00%195M | 0.00%18M | -500.00%-20M | 500.00%36M | 140.00%14M | -104.76%-1M | 550.00%18M | -79.17%5M | 106.82%6M | -105.88%-35M |
| Net income | 133.21%364M | 48.45%-50M | -68.93%32M | -1,478.21%-1.23B | -161.11%-141M | -1,586.15%-1.1B | -870.00%-97M | 101.96%103M | 83.85%-78M | 50.00%-54M |
| Net income continuous Operations | 133.21%364M | 48.45%-50M | -68.93%32M | -1,478.21%-1.23B | -161.11%-141M | -1,586.15%-1.1B | -870.00%-97M | 101.96%103M | 83.85%-78M | 50.00%-54M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 133.21%364M | 48.45%-50M | -68.93%32M | -1,478.21%-1.23B | -161.11%-141M | -1,586.15%-1.1B | -870.00%-97M | 101.96%103M | 83.85%-78M | 50.00%-54M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 133.21%364M | 48.45%-50M | -68.93%32M | -1,478.21%-1.23B | -161.11%-141M | -1,586.15%-1.1B | -870.00%-97M | 101.96%103M | 83.85%-78M | 50.00%-54M |
| Basic earnings per share | 133.33%0.74 | 50.00%-0.1 | -71.43%0.06 | -1,462.50%-2.5 | -163.64%-0.29 | -1,607.69%-2.22 | -900.00%-0.2 | 110.00%0.21 | 83.84%-0.16 | 45.00%-0.11 |
| Diluted earnings per share | 132.88%0.73 | 50.00%-0.1 | -71.43%0.06 | -1,462.50%-2.5 | -163.64%-0.29 | -1,607.69%-2.22 | -900.00%-0.2 | 110.00%0.21 | 83.84%-0.16 | 45.00%-0.11 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data